Clinical Trials Browser

Phase 2 × Adenocarcinoma × Sunitinib × Clear all

Adenocarcinoma, Adenoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Pancreatic Diseases, Pancreatic Neoplasms, Neuroectodermal Tumors, Neuroendocrine Tumors

NCT01020630 2014-05-14

SUN-CASE

Phase 2 Completed

91 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT01215565 2014-03-13

Fibrolam

Phase 2 Terminated

4 enrolled

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pathologic Processes

NCT00430261 2010-10-06

Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma

Phase 2 Completed

20 enrolled

Thoracic

Adenocarcinoma, Adenocarcinoma, Bronchiolo-Alveolar, Lung Neoplasms

Clinical Trials

NET

SUN-CASE

Fibrolam

Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma